Zobrazeno 1 - 10
of 10
pro vyhledávání: '"SAGE, Strategic Advisory Group of Experts"'
Autor:
Stefano Malvolti, Carsten Mantel, Chantal Veira, Alan R. Hinman, Thomas Cherian, Noni E. MacDonald, Christoph Steffen, Angela Hwang, Ian M. Jones
Publikováno v:
Vaccine
Highlights • The M&E/A framework was a critically important element of GVAP. • It was a cyclical process of monitoring, review, and recommendations for action. • Though a step in the right direction, it failed to hold all stakeholders accountab
Autor:
Chantal Veira, Stefano Malvolti, Angela Hwang, Ian M. Jones, Carsten Mantel, Alan R. Hinman, Christoph Steffen, Thomas Cherian, Noni E. MacDonald
Publikováno v:
Vaccine
Highlights • GVAP built visibility for immunization and was an improvement over prior plans. • GVAP implementation was incomplete due to limited awareness and stakeholder buy-in. • The GVAP Monitoring & Evaluation/Accountability framework gave
Autor:
Shaghayegh Haghjooy Javanmard, Abbas Alibakhshi, Elmira Mohammadi, Sahar Esfandyari, Leila Beikmohammadi, Samira Bahrami, Mohammad Mehdi Ranjbar, Shahrzad Ahangarzadeh, Fatemeh Mahmoudian, Kiana Shahzamani
Publikováno v:
International Immunopharmacology
COVID-19 is still a deadly disease that remains yet a major challenge for humans. In recent times, many large pharmaceutical and non-pharmaceutical companies have invested a lot of time and cost in fighting this disease. In this regard, today's scien
Autor:
Lisa Jacques-Carroll, Federico Martinón-Torres, Annelies Wilder-Smith, Ole Wichmann, Thomas Harder, Liudmila Mosina, Siddhartha Sankar Datta, Andrew Earnshaw, Wiebe Külper-Schiek
Publikováno v:
Vaccine, 39(45):6595-6600
Vaccine
Vaccine
National Immunization Technical Advisory Groups are groups of multi-disciplinary experts that provide scientific advice to policy makers to enable them to make informed immunization policy and programme decisions. NITAGs faced challenges using their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8301c05fd3e098f110b0e15cc42df63c
https://researchonline.lshtm.ac.uk/id/eprint/4663899/1/1-s2.0-S0264410X21012251-main.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4663899/1/1-s2.0-S0264410X21012251-main.pdf
Publikováno v:
Vaccine
Highlights • Practical, evidence-informed advice considers the spectrum of public health science. • This framework fills a gap in the comprehensive development of vaccine guidance. • It enables the systematic examination of ethics, equity, feas
Autor:
Katherine E, Gallagher, Helen, Kelly, Naomi, Cocks, Sandra, Dixon, Sandra, Mounier-Jack, Natasha, Howard, Deborah, Watson-Jones
Publikováno v:
Papillomavirus Research, Vol 6, Iss, Pp 33-40 (2018)
Papillomavirus Research
Papillomavirus Research
Background: The World Health Organization (WHO) recommends a 2-dose HPV vaccine schedule for girls aged 9–14 years. As randomised controlled trials assessing the immunogenicity and efficacy of a 1-dose schedule are ongoing, we interviewed immunisat
Autor:
Mercy Mvundura, Debra Kristensen, Courtney Jarrahian, Collrane Frivold, Shanda Boyle, Jui-Shan Hsu, Darin Zehrung
Publikováno v:
Vaccine: X
Vaccine: X, Vol 2, Iss, Pp-(2019)
Vaccine: X, Vol 2, Iss, Pp-(2019)
Introduction: Inactivated poliovirus vaccine (IPV) shortages and evidence of improved immunogenicity of two intradermal (ID) fractional IPV (fIPV) doses compared with one full intramuscular dose led to recommendations for fIPV delivery. To provide ev
Exploring enablers and barriers toward COVID-19 vaccine acceptance among Arabs: A qualitative study.
Autor:
Elbarazi I; Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, AlAin, United Arab Emirates., Yacoub M; English Department, Florida International University, Miami, FL, USA., Reyad OA; Internal Medicine and Cardiology Clinical Pharmacy Department, Alexandria Main University Hospital, Alexandria, Egypt., Abdou MS; Department of Epidemiology, High Institute of Public Health, Alexandria University, Egypt., Elhadi YAM; Department of Public Health, Medical Research Office, Sudanese Medical Research Association, Khartoum, Sudan., Kheirallah KA; Department of Public Health, Medical School of Jordan University of Science and Technology, Irbid, Jordan., Ababneh BF; Department of Public Health, Medical School of Jordan University of Science and Technology, Irbid, Jordan., Hamada BA; Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, AlAin, United Arab Emirates., El Saeh HM; Community Medicine Department, Faculty of Medicine, University of Tripoli, Tripoli, Libya., Ali N; Department of Communication and Media, Indiana University of Pennsylvania, Pennsylvania, USA., Rahma AT; Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, AlAin, United Arab Emirates., Tahoun MM; Department of Epidemiology, High Institute of Public Health, Alexandria University, Egypt., Ghazy RM; Tropical Health Department, High Institute of Public Health, Alexandria University, Egypt.
Publikováno v:
International journal of disaster risk reduction : IJDRR [Int J Disaster Risk Reduct] 2022 Nov; Vol. 82, pp. 103304. Date of Electronic Publication: 2022 Sep 29.
Autor:
Mvundura M; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Hsu JS; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Frivold C; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Kristensen D; PATH, Rue de Varembé 7, 1202 Geneva, Switzerland., Boyle S; Bill & Melinda Gates Foundation, 500 Fifth Avenue North, Seattle, WA 98109, USA., Zehrung D; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Jarrahian C; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA.
Publikováno v:
Vaccine: X [Vaccine X] 2019 Jul 15; Vol. 2, pp. 100032. Date of Electronic Publication: 2019 Jul 15 (Print Publication: 2019).
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2015; Vol. 11 (4), pp. 991-7.